George Brady

(The following information was supplied by the firm)

George is a partner in the firm’s Corporate Department. He has advised on many of the most significant Irish corporate transactions of recent years including:

  • Allergan’s $66 billion merger with Actavis.
  • Unsuccesful bid to acquire eircom from examinership on behalf of an international telecommunications group.
  • The Actavis $8.5 billion acquisition of Warner Chilcott.
  • The $6.5 billion hostile bid by Royalty Pharma for Elan Corporation.
  • Medtronic’s proposed $42.9 billion acquisition of Covidien plc.
  • Eaton Corporation’s $11.8 billion acquisition of Cooper Industries.
  • The $5.6 billion merger of Questcor and Mallinckrodt.
  • Babcock & Brown on its €2.3 billion acquisition of eircom.
  • The $2.6 billion acquisition of Auxilium Pharmaceuticals by Endo International.

George previously worked in the London office of a leading international law firm and has been a partner since 2003.

Sign In

[login_form] Lost Password